Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Geron(GERN) Businesswire·2024-03-19 21:07公司融资 - Geron Corporation宣布定价41,999,998股普通股和8,002,668股预先融资认股权证[1] - 该交易预计募集约1.5亿美元，用于潜在的imetelstat在美国和欧盟的商业化以及在relapsed/refractory myelofibrosis的持续发展[2] - TD Cowen、Stifel和Barclays担任本次交易的联席主承销商，Wedbush PacGrow担任副主承销商[3]